Implantable insulin pumps are becoming a necessity with surge in prevalence of diabetes across the world.
Implantable Insulin Pump Market Overview:
Implantable insulin pumps are becoming a necessity with surge in prevalence of diabetes across the world. Medical device manufacturers adopted various strategies such as agreements and new product launches to raise their stakes in the market and solve existing issues. From buying intellectual property rights and developing advanced products in collaboration to launching innovative products, market players are striding to treat different types of diabetes. They are focused on developing compact, lightweight, and technologically advanced devices that provide precise delivery of insulin. The demand for implantable insulin pumps that release appropriate amount of insulin will grow in the next few years. According to the report published by Allied Market Research, the global implantable insulin pump market is estimated to reach $6.44 billion by 2030. Following are some of the activities taking place across the world.
Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/3419
Market players have adopted various strategies to serve diabetic patients at different regions. Medtronic, one of the leading medical device developers, adopted the strategy of agreement. It signed an agreement and bought the intellectual property rights of implantable insulin pump developed by the Alfred E. Mann Foundation for Scientific Research. These insulin pumps are different than conventional pumps. These pumps offer increased precision in delivery, occlusion detection, and MRI compatibility. In addition, they are smaller and more lightweight than existing insulin pumps.
Top Leading Players:
- Apex Medical
- CVS Health (Aetna Inc.)
- Diabeloop
- Diamesco Co., Ltd
- F. Hoffmann La Roche Ltd
- Insulet Corporation
- Johnson & Johnson
- Medtronic Plc
- SOOIL Developments Co. Ltd
- Tandem Diabetes Care.
Under the agreement strategy, Medtronic and the Mann Foundation will collaborate for development of advanced technology and bring an innovative type of implantable insulin pump. Moreover, this device is aimed at enhancing insulin delivery for people suffering from Type 1 diabetes. Both companies are targeting patients from the European region. Medtronic will utilize its expertise in development and commercialization of implantable devices and Mann Foundation will bring its technology. Such collaboration activity will lead to development of novel implantable devices for diabetic patients.
Along with the agreement strategy, new product launches is another strategy adopted by market players. Sernova launched its implantable insulin pump called as Cell Pouch. The device is implanted under the skin of diabetic patients. It contains purified insulin-producing islets. These islets develop insulin naturally. The feedback system linked to the levels of glucose is used to release appropriate amount of insulin. This device is of the size of business card and can be implanted with the help of simple procedure. Such innovative devices will continue to be launched across the world as medical device manufacturers determine the existing gaps and provide solutions.
Impact of COVID-19 Pandemic on Implantable Insulin Pump Market:
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The COVID-19 pandemic has disrupted virtually each aspect of healthcare provision, including diabetes care. The impact of this pandemic on the implantable insulin pump market will provide learnings to medical device companies across other therapy areas both in the short and the long term.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com